{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T04:57:12Z","timestamp":1791003432211,"version":"4.1.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2008,3,14]],"date-time":"2008-03-14T00:00:00Z","timestamp":1205452800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1186\/bcr1868","type":"journal-article","created":{"date-parts":[[2008,3,27]],"date-time":"2008-03-27T19:14:51Z","timestamp":1206645291000},"source":"Crossref","is-referenced-by-count":5,"title":["Breast cancer surface receptors predict risk for developing brain metastasis and subsequent prognosis"],"prefix":"10.1186","volume":"10","author":[{"given":"Jai","family":"Grewal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santosh","family":"Kesari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,3,14]]},"reference":[{"key":"1832_CR1","doi-asserted-by":"publisher","first-page":"R20","DOI":"10.1186\/bcr1870","volume":"10","author":"B-H Nam","year":"2008","unstructured":"Nam B-H, Kim SY, Han HS, Kwon Y, Lee KS, Kim TH, Ro J: Breast cancer subtypes and survival in patients with brain metastases. Breast Cancer Res. 2008, 10: R20-10.1186\/bcr1870.","journal-title":"Breast Cancer Res"},{"key":"1832_CR2","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1097\/01.pas.0000213306.05811.b9","volume":"30","author":"DG Hicks","year":"2006","unstructured":"Hicks DG, Short SM, Prescott NL, Tarr SM, Coleman KA, Yoder BJ, Crowe JP, Choueiri TK, Dawson AE, Budd GT, Tubbs RR, Casey G, Weil RJ: Breast cancers with brain metastases are more likely to be estrogen receptor negative, express the basal cytokeratin CK5\/6, and overexpress HER2 or EGFR. Am J Surg Pathol. 2006, 30: 1097-1104.","journal-title":"Am J Surg Pathol"},{"key":"1832_CR3","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1093\/annonc\/mdg300","volume":"14","author":"KD Miller","year":"2003","unstructured":"Miller KD, Weathers T, Haney LG, Timmerman R, Dickler M, Shen J, Sledge GW: Occult central nervous system involvement in patients with metastatic breast cancer: prevalence, predictive factors and impact on overall survival. Ann Oncol. 2003, 14: 1072-1077. 10.1093\/annonc\/mdg300.","journal-title":"Ann Oncol"},{"key":"1832_CR4","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1002\/cncr.22041","volume":"107","author":"YL Tham","year":"2006","unstructured":"Tham YL, Sexton K, Kramer R, Hilsenbeck S, Elledge R: Primary breast cancer phenotypes associated with propensity for central nervous system metastases. Cancer. 2006, 107: 696-704. 10.1002\/cncr.22041.","journal-title":"Cancer"},{"key":"1832_CR5","first-page":"1936","volume":"21","author":"R Weitzen","year":"2002","unstructured":"Weitzen R, Zach L, Kaufman B, Tichler T, Rath P, Pfeffer R: High incidence of brain metastasis (BM) in patients on trastuzumab (H) for advanced breast cancer [abstract]. Proc Am Soc Clin Oncol. 2002, 21: 1936-","journal-title":"Proc Am Soc Clin Oncol"},{"key":"1832_CR6","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1158\/1078-0432.CCR-06-1109","volume":"13","author":"LA Carey","year":"2007","unstructured":"Carey LA, Dees EC, Sawyer L, Gatti L, Moore DT, Collichio F, Ollila DW, Sartor CI, Graham ML, Perou CM: The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes. Clin Cancer Res. 2007, 13: 2329-2334. 10.1158\/1078-0432.CCR-06-1109.","journal-title":"Clin Cancer Res"},{"key":"1832_CR7","volume-title":"J Clin Oncol","author":"C Liedtke","year":"2008","unstructured":"Liedtke C, Mazouni C, Hess KR, Andr\u00e9 F, Tordai A, Mejia JA, Symmans WF, Gonzalez-Angulo AM, Hennessy B, Green M, Cristofanilli M, Hortobagyi GN, Pusztai L: Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer. J Clin Oncol. 2008"},{"key":"1832_CR8","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1200\/JCO.2000.18.11.2349","volume":"18","author":"BC Pestalozzi","year":"2000","unstructured":"Pestalozzi BC, Brignoli S: Trastuzumab in CSF. J Clin Oncol. 2000, 18: 2349-2351.","journal-title":"J Clin Oncol"},{"key":"1832_CR9","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/01.cad.0000236313.50833.ee","volume":"18","author":"HJ Stemmler","year":"2007","unstructured":"Stemmler HJ, Schmitt M, Willems A, Bernhard H, Harbeck N, Heinemann V: Ratio of trastuzumab levels in serum and cerebrospinal fluid is altered in HER2-positive breast cancer patients with brain metastases and impairment of blood-brain barrier. Anticancer Drugs. 2007, 18: 23-28. 10.1097\/01.cad.0000236313.50833.ee.","journal-title":"Anticancer Drugs"},{"key":"1832_CR10","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1200\/JCO.2001.19.13.3297","volume":"19","author":"RH Baculi","year":"2001","unstructured":"Baculi RH, Suki S, Nisbett J, Leeds N, Groves M: Meningeal carcinomatosis from breast carcinoma responsive to trastuzumab. J Clin Oncol. 2001, 19: 3297-3298.","journal-title":"J Clin Oncol"},{"key":"1832_CR11","doi-asserted-by":"publisher","first-page":"4130","DOI":"10.1200\/JCO.2002.04.016","volume":"20","author":"IB Fuchs","year":"2002","unstructured":"Fuchs IB, Loebbecke M, Buhler H, Stoltenburg-Didinger G, Heine B, Lichtenegger W, Schaller G: HER2 in brain metastases: issues of concordance, survival, and treatment. J Clin Oncol. 2002, 20: 4130-4133. 10.1200\/JCO.2002.04.016.","journal-title":"J Clin Oncol"},{"key":"1832_CR12","doi-asserted-by":"crossref","first-page":"11512","DOI":"10.1200\/jco.2007.25.18_suppl.11512","volume":"25","author":"J Grewal","year":"2007","unstructured":"Grewal J, Groves MD, Bekele BN, Yung WA: The role of HER2\/neu, estrogen, and progesterone receptor status in the risk and survival of breast cancer leptomeningeal metastasis (2007 ASCO Annual Meeting Proceedings Part I) [abstract]. J Clin Oncol. 2007, 25: 11512-","journal-title":"J Clin Oncol"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/bcr1868.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/bcr1868\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/bcr1868.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,3]],"date-time":"2020-05-03T14:08:21Z","timestamp":1588514901000},"score":1,"resource":{"primary":{"URL":"http:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/bcr1868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3,14]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["1832"],"URL":"https:\/\/doi.org\/10.1186\/bcr1868","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3,14]]},"article-number":"104"}}